{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:33:42Z","timestamp":1791419622517,"version":"4.3.3"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,3]]},"DOI":"10.1212\/wnl.48.3.626","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:27:33Z","timestamp":1336915653000},"page":"626-632","source":"Crossref","is-referenced-by-count":854,"title":["Risk of Alzheimer's disease and duration of NSAID use"],"prefix":"10.1212","volume":"48","author":[{"given":"Walter F.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kawas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Corrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jeffrey","family":"Metter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"8","volume":"120","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-890.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.1.4"},{"key":"e_1_3_1_4_2","first-page":"4","volume":"15","year":"1991","unstructured":"Altstiel L, Sperber K. Cytokines in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:481-495.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4838(90)90002-W"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(90)90055-5"},{"key":"e_1_3_1_7_2","first-page":"2","volume":"57","year":"1982","unstructured":"Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques: an immunohistochemical study. Acta Neuropathol (Berl) 1982;57:239-252.","journal-title":"Acta Neuropathol (Berl)"},{"key":"e_1_3_1_8_2","first-page":"3","volume":"107","year":"1989","unstructured":"McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 1989;107:341-346.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(87)90662-8"},{"key":"e_1_3_1_10_2","first-page":"2","volume":"44","year":"1994","unstructured":"Anonymous. The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.","journal-title":"Neurology"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"44","year":"1994","unstructured":"Breitner JCS, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology 1994;44:227-232.","journal-title":"Neurology"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(95)80002-9"},{"key":"e_1_3_1_13_2","first-page":"8","volume":"36","year":"1994","unstructured":"Lucca U, Tettamanti M, Forloni G, Spagnoli A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994;36:854-856.","journal-title":"Biol Psychiatry"},{"key":"e_1_3_1_14_2","first-page":"1","volume":"45","year":"1995","unstructured":"Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MMB, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? Neurology 1995;45:1441-1445.","journal-title":"Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? Neurology"},{"key":"e_1_3_1_15_2","unstructured":"Kukull WA Larson EG Stergachis A et al. Non-steroidal anti-inflammatory drug use and risk of Alzheimer's disease [abstract]. Neurology 1994;44(suppl 2):A237."},{"key":"e_1_3_1_16_2","unstructured":"Shock N Greulich R Andres R et al. Normal human aging: the Baltimore Longitudinal Study of Aging (NIH Publication No. 84-2450). Washington DC: US Government Printing Office 1984."},{"key":"e_1_3_1_17_2","first-page":"7","volume":"114","year":"1968","unstructured":"Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811.","journal-title":"Br J Psychiatry"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90017-5"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/87565648709540360"},{"key":"e_1_3_1_20_2","unstructured":"Kaplan E Goodglass H Weintraub S. The Boston Naming Test. Boston MA: Kaplan and Goodglass 1978."},{"key":"e_1_3_1_21_2","first-page":"5","volume":"6","year":"1968","unstructured":"Benton AL. Differential behavioral effects in frontal lobe disease. Neuropsychologia 1968;6:53-60.","journal-title":"Neuropsychologia"},{"key":"e_1_3_1_22_2","unstructured":"Army Individual Test Battery. Manual of directions and scoring. Washington DC: War Department Adjuvant General's Office 1944."},{"key":"e_1_3_1_23_2","first-page":"7","volume":"18","year":"1992","unstructured":"Rouleau I, Salmon DP, Butters N, Kennedy C, McGuire K. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn 1992;18:70-87.","journal-title":"Brain Cogn"},{"key":"e_1_3_1_24_2","first-page":"6","volume":"24","year":"1988","unstructured":"Morris JC, Mohs R, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a Registry for Alzheimer's Disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 1988;24:641-652.","journal-title":"Psychopharmacol Bull"},{"key":"e_1_3_1_25_2","first-page":"3","volume":"1","year":"1977","unstructured":"Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.","journal-title":"Appl Psychol Meas"},{"key":"e_1_3_1_26_2","first-page":"3","volume":"37","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329.","journal-title":"J Gerontol"},{"key":"e_1_3_1_27_2","first-page":"2","volume":"14","year":"1978","unstructured":"Nelson HE, O'Connell A. Dementia: the estimation of premorbid intelligence using the New Adult Reading Test. Cortex 1978;14:234-244.","journal-title":"Cortex"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1994.00540130015002"},{"key":"e_1_3_1_29_2","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed rev. Washington DC: American Psychiatric Association 1987."},{"key":"e_1_3_1_30_2","first-page":"9","volume":"34","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.","journal-title":"Neurology"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2517-6161.1972.tb00885.x","volume":"34","year":"1972","unstructured":"Cox DR. Regression models and life tables. J Royal Stat Society, Series B 1972;34:187-220.","journal-title":"J Royal Stat Society, Series B"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.2307\/3575018"},{"key":"e_1_3_1_33_2","unstructured":"Checkoway H Pearce NE Crawford-Brown DJ. Research methods in occupational epidemiology monographs in epidemiology and biostatistics vol 13. New York: Oxford University Press 1989:153-155."},{"key":"e_1_3_1_34_2","first-page":"6","volume":"243","year":"1980","unstructured":"Aspirin Myocardial Infarction Study Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980;243:661-669.","journal-title":"JAMA"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199407073310101"},{"key":"e_1_3_1_36_2","unstructured":"Paulas HE. Nonsteroidal anti-inflammatory drugs. In: Kelley WN Harris ED Ruddy S Sledge CB eds. A textbook of rheumatology. Philadelphia: WB Saunders 1989."},{"key":"e_1_3_1_37_2","unstructured":"Corrada M Stewart W Kawas C. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease [abstract]. Neurology 1996;46(suppl 2):A433."},{"key":"e_1_3_1_38_2","unstructured":"Borne RF. Nonsteroidal anti-inflamatory drugs. In: Foye WO Lemke TL Williams DA eds. Principles of medicinal chemistry. 4th ed. Media PA: Williams & Wilkins 1995."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.48.3.626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T22:29:27Z","timestamp":1743114567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.48.3.626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["10.1212\/WNL.48.3.626"],"URL":"https:\/\/doi.org\/10.1212\/wnl.48.3.626","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}